Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126588551 | 12658855 | 1 | I | 20160803 | 20160817 | 20160817 | EXP | GB-B. BRAUN MEDICAL INC.-1056403 | B BRAUN | 23.00 | YR | F | Y | 46.20000 | KG | 20160817 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126588551 | 12658855 | 1 | PS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 19635 | ||||||||||||
| 126588551 | 12658855 | 2 | SS | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | U | 2PT16001UK | 0 | 4.5 | G | |||||||
| 126588551 | 12658855 | 3 | C | Calcichew D3 | CALCIUMCHOLECALCIFEROL | 1 | Oral | 0 | |||||||||||
| 126588551 | 12658855 | 4 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | 0 | 10000 | IU | ||||||||||
| 126588551 | 12658855 | 5 | C | Dornase Alfa(Deoxyribonuclease) | 2 | Respiratory (inhalation) | 0 | 2.5 | MG | ||||||||||
| 126588551 | 12658855 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | |||||||||
| 126588551 | 12658855 | 7 | C | Salbutamol | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | 100 | UG | |||||||||
| 126588551 | 12658855 | 8 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Respiratory (inhalation) | 0 | 7 | PCT | |||||||||
| 126588551 | 12658855 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 126588551 | 12658855 | 10 | C | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 0 | 460 | MG | |||||||||
| 126588551 | 12658855 | 11 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 0 | 400 | IU | |||||||||
| 126588551 | 12658855 | 12 | C | VITAMIN K | PHYTONADIONE | 1 | Oral | 0 | 10 | MG | |||||||||
| 126588551 | 12658855 | 13 | C | Vitamin Supplement | VITAMINS | 1 | Oral | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126588551 | 12658855 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126588551 | 12658855 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126588551 | 12658855 | 2 | 20160627 | 20160702 | 0 | |
| 126588551 | 12658855 | 10 | 20160627 | 0 |